Intravenous ritodrine therapy: a comparison between twin and singleton gestations

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Pharmacology

Background:

• Premature labor is a significant concern in singleton and twin pregnancies.
• Intravenous ritodrine is a common tocolytic agent used to manage premature labor.
• The efficacy and safety of ritodrine in twin gestations require specific evaluation.

Purpose of the Study:

• To assess if current guidelines for intravenous ritodrine therapy in singleton pregnancies are applicable to twin gestations.
• To compare maternal and fetal cardiovascular responses to ritodrine in twin versus singleton pregnancies.
• To evaluate the safety and efficacy of ritodrine therapy in managing premature labor in twin pregnancies.

Main Methods:

• Retrospective analysis of women admitted with premature labor between January 1982 and March 1985.
• Identification of pregnancies with twin fetuses (n=43) and those receiving intravenous ritodrine therapy for ≥4 hours (n=23).
• Comparison of cardiovascular parameters and treatment outcomes between the twin gestation group and a matched group of 23 singleton pregnancies.

Main Results:

• No significant differences were observed in maternal and fetal heart rates or maternal diastolic blood pressure between twin and singleton groups.
• Adverse cardiovascular effects were not more frequent in twin gestations and primarily occurred during rapid dose escalation.
• Average ritodrine doses, therapy duration, and delay in delivery were comparable between the twin and singleton groups.

Conclusions:

• Intravenous ritodrine therapy guidelines for singleton pregnancies can likely be applied to twin gestations.
• Ritodrine demonstrates a similar safety profile and efficacy in managing premature labor for both singleton and twin pregnancies.
• Further research may confirm these findings and refine treatment protocols for tocolysis in multifetal gestations.